Income Taxes (Tables)
|
12 Months Ended |
Dec. 31, 2025 |
|---|
| Income Tax Disclosure [Abstract] |
|
| Schedule of components of loss before income taxes |
| Schedule of components of loss before income taxes |
|
|
|
|
|
|
| |
|
Year ended December 31, |
|
| |
|
2025 |
|
|
2024 |
|
| Domestic (U.S.) |
|
$ |
(5,466,353 |
) |
|
$ |
(6,251,785 |
) |
| Foreign (U.K.) |
|
|
2,966,647 |
|
|
|
2,460,945 |
|
| Foreign (Germany) |
|
|
(164,853 |
) |
|
|
(153,332 |
) |
| Foreign (Switzerland) |
|
|
(16,301 |
) |
|
|
(16,103 |
) |
| Loss before income taxes |
|
$ |
(2,680,860 |
) |
|
$ |
(3,960,275 |
) |
|
| Schedule of components of loss before income taxes |
| Schedule of components of loss before income taxes |
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
Year ended December 31, |
|
| |
|
2025 |
|
|
2024 |
|
| Federal |
|
$ |
(562,981 |
) |
|
|
21.0% |
|
|
$ |
(831,658 |
) |
|
|
21.0% |
|
| Domestic Federal |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Tax credits |
|
|
(117,620 |
) |
|
|
4.4 |
|
|
|
(120,379 |
) |
|
|
3.0 |
|
| Effect of cross-border tax laws |
|
|
430,088 |
|
|
|
(16.0 |
) |
|
|
153,506 |
|
|
|
(3.9 |
) |
| Change in valuation allowance |
|
|
(759,494 |
) |
|
|
28.3 |
|
|
|
1,057,187 |
|
|
|
(26.7 |
) |
| Share-based expense, net |
|
|
1,105,585 |
|
|
|
(41.2 |
) |
|
|
223,523 |
|
|
|
(5.6 |
) |
| Other |
|
|
489,375 |
|
|
|
(18.3 |
) |
|
|
(962 |
) |
|
|
– |
|
| Foreign |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| United Kingdom |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Rate differential |
|
|
113,467 |
|
|
|
(4.2 |
) |
|
|
93,731 |
|
|
|
(2.4 |
) |
| Valuation allowance |
|
|
(703,161 |
) |
|
|
26.2 |
|
|
|
37,533 |
|
|
|
(0.9 |
) |
| Attribute adjustments |
|
|
– |
|
|
|
– |
|
|
|
(617,109 |
) |
|
|
15.6 |
|
| Other |
|
|
(33,301 |
) |
|
|
1.2 |
|
|
|
(30,954 |
) |
|
|
0.8 |
|
| Other |
|
|
38,042 |
|
|
|
(1.4 |
) |
|
|
35,582 |
|
|
|
(0.9) |
|
| Net benefit for income taxes |
|
$ |
– |
|
|
|
– |
|
|
$ |
– |
|
|
|
– |
|
|
| Schedule of deferred tax assets and liabilities |
| Schedule of deferred tax assets and liabilities |
|
|
|
|
|
|
| |
|
Year ended December 31, |
|
| |
|
2025 |
|
|
2024 |
|
| Deferred tax assets: |
|
|
|
|
|
|
|
|
| U.K. net operating loss carryforwards |
|
$ |
21,235,111 |
|
|
$ |
21,938,273 |
|
| U.K. capital loss carryforwards |
|
|
1,745,821 |
|
|
|
1,745,821 |
|
| U.S. federal net operating loss carryforwards |
|
|
8,127,082 |
|
|
|
7,518,011 |
|
| Switzerland net operating loss carryforwards |
|
|
22,480 |
|
|
|
13,392 |
|
| IPR&D |
|
|
534,753 |
|
|
|
586,746 |
|
| Share-based expense |
|
|
429,581 |
|
|
|
1,979,372 |
|
| Enhanced research and development tax credits |
|
|
2,278,855 |
|
|
|
2,165,119 |
|
| Germany net operating loss carryforwards |
|
|
844,276 |
|
|
|
700,617 |
|
| Capitalized research and experimental expenditure |
|
|
1,660,590 |
|
|
|
1,804,979 |
|
| U.S. state net operating loss carryforwards |
|
|
2,762,009 |
|
|
|
2,468,919 |
|
| Other |
|
|
151,294 |
|
|
|
208,288 |
|
| Total deferred tax assets before valuation allowance |
|
|
39,791,852 |
|
|
|
41,129,537 |
|
| Valuation allowance for deferred tax assets |
|
|
(39,791,852 |
) |
|
|
(41,129,537 |
) |
| Net deferred tax assets |
|
|
– |
|
|
|
– |
|
| Deferred tax liabilities: |
|
|
|
|
|
|
|
|
| Total deferred tax liabilities |
|
|
– |
|
|
|
– |
|
| Net deferred liability |
|
$ |
– |
|
|
$ |
– |
|
|